„reprogramming“
Suchergebnisse
2.540 Treffer
-
Reprogram Yourself!
-
Cellular Reprogramming of Somatic Cells to Stem Cells: an Innovative Approach in Pharmaceutical Biotechnology
-
When cellular reprogramming meets AI: towards de novo cell design
-
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles
-
Integrated single-cell and transcriptomic analysis of bone marrow-derived metastatic neuroblastoma reveals molecular mechanisms of metabolic reprogramming
-
NF-κB inactivation in myeloid cell leads to reprogramming of whole-body energy metabolism in response to high-fat diet
-
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
-
Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke
-
Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma
-
Hydrogel‐Based ROS‐Regulating Strategy: Reprogramming the Oxidative Stress Imbalance in Advanced Diabetic Wound Repair
-
Bisphenol A causes melatonin biosynthesis epigenetic reprogramming of melatonin biosynthesis genes in arabidopsis thaliana
-
PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3
-
Metabolism‐Regulating Nanomedicines for Cancer Therapy
-
IGFBP1 orchestrates metabolic reprogramming to drive clear cell renal cell carcinoma progression through NR1H4-mediated lipid homeostasis disruption
-
SMAD3 and HIF-1α orchestrate metabolic transition to aerobic glycolysis as a critical prerequisite for spontaneous reprogramming of spermatogonial stem cells
-
Stress granules shape metabolic reprogramming and drug resistance
-
Metabolic reprogramming via FOXP3 engineering: A Novel strategy to enhance CAR-T cell efficacy in solid tumors
-
Reprogramming of hsa_circ_0008719 and its target miR-3615 induced by TOB1 in exosomes of gastric cancer cells: a contribution to inhibit gastric cancer progression
-
ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer
-
Metabolic reprogramming and prognostic insights in molecular landscapes driven by glycolysis in ovarian cancer